|
2025
|
P/S
|
Pharmaceutical preparations for the treatment of diseases in the field of neuroscience, namely, d... |
|
2023
|
Invention
|
Methods of administering r-ketamine.
The disclosure provides a method of treating or amelioratin... |
|
|
Invention
|
Methods of administering r-ketamine. The disclosure provides a method of treating or ameliorating... |
|
|
Invention
|
Pharmaceutical formulations of r-ketamine.
The present disclosure is directed to R-ketamine form... |
|
|
Invention
|
Pharmaceutical formulations of r-ketamine. The present disclosure is directed to R-ketamine formu... |
|
2022
|
Invention
|
R-ketamine salts and methods of use thereof.
The present disclosure relates to novel salts and s... |
|
|
Invention
|
R-ketamine salts and methods of use thereof. RR)-2-(2-chlorophenyl)-2- (methylamino)cyclohexan-1-... |
|
|
Invention
|
Methods of treating substance abuse.
The disclosure provides a method of treating a substance us... |
|
2021
|
P/S
|
Pharmaceuticals for the treatment of diseases in the field of neuroscience, namely, depressive sy... |
|
|
P/S
|
Scientific and medical research in the field of neuroscience, namely, depressive symptoms in a va... |
|
2019
|
Invention
|
Methods of treating substance abuse. The disclosure provides a method of treating a substance use... |
